Off-label psychopharmacologic prescribing for children: history supports close clinical monitoring.
The review presents pediatric adverse drug events from a historical perspective and focuses on selected safety issues associated with off-label use of medications for the psychiatric treatment of youth. Clinical monitoring procedures for major psychotropic drug classes are reviewed. Prior studies suggest that systematic treatment monitoring is warranted so as to both minimize risk of unexpected adverse events and exposures to ineffective treatments. Clinical trials to establish the efficacy and safety of drugs currently being used off-label in the pediatric population are needed. In the meantime, clinicians should consider the existing evidence-base for these drugs and institute close clinical monitoring.
Zito
Julie M
JM
Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA. jzito@rx.umaryland.edu
Derivan
Albert T
AT
Kratochvil
Christopher J
CJ
Safer
Daniel J
DJ
Fegert
Joerg M
JM
Greenhill
Laurence L
LL
Drug Saf. 2008;31(2):169-80
18217792
Pediatr Neurol. 2003 Feb;28(2):145-8
12699868
Pediatrics. 1987 Aug;80(2):165-74
3112727
Am J Health Syst Pharm. 2003 Oct 1;60(19):2007-14
14531250
N Engl J Med. 1993 Nov 4;329(19):1383-8
8413434
J Clin Psychiatry. 2001;62 Suppl 14:16-21
11469670
JAMA. 2004 Aug 18;292(7):807-20
15315995
Pediatrics. 2008 Jan;121(1):e157-63
18166534
Crit Care Med. 1995 Feb;23(2):405-9
7867366
Psychiatr Serv. 2006 May;57(5):681-5
16675763
J Child Adolesc Psychopharmacol. 2006 Jun;16(3):308-16
16768638
Am J Psychiatry. 1990 Feb;147(2):207-10
2301661
Biol Psychiatry. 2001 Jun 15;49(12):1015-22
11430843
J Am Acad Child Adolesc Psychiatry. 2001 Jun;40(6):622-9
11392339
JAMA. 2006 May 3;295(17):2072-5
16670415
Pharmacopsychiatry. 2004 Nov;37(6):243-65
15551191
J Child Adolesc Psychopharmacol. 2003 Summer;13(2):143-52
12886909
Arch Gen Psychiatry. 1997 Nov;54(11):1031-7
9366660
Arch Pediatr Adolesc Med. 2003 Jan;157(1):17-25
12517190
J Am Acad Child Adolesc Psychiatry. 2002 Jul;41(7):785-90
12108802
N Engl J Med. 2006 Apr 6;354(14):1445-8
16549404
Neurology. 1996 Feb;46(2):465-9
8614514
Pharmacopsychiatry. 1992 Nov;25(6):271-2
1494593
BMJ. 2002 Aug 3;325(7358):243
12153919
Z Kinder Jugendpsychiatr Psychother. 2006 Jan;34(1):5-13
16485609
Psychiatr Serv. 2001 Aug;52(8):1081-7
11474055
Anaesthesia. 1988 Jul;43(7):593-8
3261948
Pediatrics. 1982 Jul;70(1):75-8
7088637
J Clin Gastroenterol. 1991 Dec;13(6):690-3
1761843
Epilepsia. 1988 Sep-Oct;29(5):530-42
3137017
J Am Acad Child Adolesc Psychiatry. 2004 Feb;43(2):215-20
14726729
J Am Acad Child Adolesc Psychiatry. 2006 Jul;45(7):771-91
16832314
Infect Control Hosp Epidemiol. 1991 Sep;12(9):535-9
1940276
J Am Med Assoc. 1949 Feb 26;139(9):572-8
18123547
N Engl J Med. 1990 Feb 8;322(6):364-9
2242106
CMAJ. 2004 Feb 17;170(4):489-91
14970097
N Engl J Med. 1960 Apr 21;262:787-94
13843700
J Pediatr. 1979 Sep;95(3):361-5
381616
J Am Acad Child Adolesc Psychiatry. 1991 Mar;30(2):179-86
2016219
Neuropsychopharmacology. 2006 Apr;31(4):689-99
16395296
J Am Acad Child Adolesc Psychiatry. 2008 Jan;47(1):9-20
18174821
JAMA. 2003 Aug 20;290(7):905-11
12928467
J Child Neurol. 2004 Aug;19 Suppl 1:S25-38
15526968
Pharmacopsychiatry. 2007 Mar;40(2):72-6
17447177
JAMA. 1963 Sep 28;185:1008-11
14045567
Pediatrics. 1957 Mar;19(3):504-24
13408030
J Clin Psychopharmacol. 2004 Aug;24(4):429-36
15232335
Int J Clin Pharmacol Ther. 1998 Oct;36(10):530-3
9799056
Epilepsia. 1997 Aug;38(8):881-6
9579888
Neurology. 1987 Mar;37(3):379-85
3102998
Am J Psychiatry. 2003 Mar;160(3):438-49
12611822